PROTECTION AGAINST MIGRAINES

Findings published in Cephalalgia found people who are treated for diabetes are less likely to be treated for migraines. The results concluded at the University of Bergen in Norway suggest that diabetes – or the medication – forms a protective factor and, with further investigation, researchers hope to gain an insight into the mechanisms of, and possible improvement in, the treatment of the migraine.